HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Calcium Study Shows Challenges Of Industry Response To Research

This article was originally published in The Tan Sheet

Executive Summary

A study warning of cardiac dangers from the use of calcium supplements shows the difficulty industry faces in responding to negative research about dietary supplements.

You may also be interested in...



Analysis Finding Low Cardio Benefit From Nutrients Has Critics In Industry, Science

Meta-analysis finds omega-3 and folate can benefit heart-related health, but says association is weak and a combination of calcium and vitamin D may increase risk of stroke. CRN says study is a “coordinated, all-out assault on nutrition” with “major” limitation of omitting epidemiological studies.

Coalition Pushes Congress On OTC Purchases With Health Savings Accounts

The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.

TheraBiogen Supports Theramax Expansion With Education Push

Homeopathic firm TheraBiogen plans to roll out products “every six to nine months” to add to its existing lineup of homeopathic remedies for allergy and cold and flu, says CEO Kelly Hickel. The firm also counts on sales growth from a social media campaign to explain what is not in its products as well as what is.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134333

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel